The reduction in RAB11A could suggest a potential anti‐inflammatory effect of epicatechin supplementation, which may help attenuate the inflammatory environment often seen in obesity, thereby improving metabolic outcomes. The gene discussed is RAB11A; the disease is obesity disorder.